UBS Group’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$188 Sell
41
-1,999
-98% -$9.17K ﹤0.01% 8609
2025
Q1
$9.96K Sell
2,040
-12,800
-86% -$62.5K ﹤0.01% 7351
2024
Q4
$99.7K Buy
14,840
+14,800
+37,000% +$99.5K ﹤0.01% 5663
2024
Q3
$308 Sell
40
-702
-95% -$5.41K ﹤0.01% 7788
2024
Q2
$4.45K Sell
742
-6,409
-90% -$38.4K ﹤0.01% 6931
2024
Q1
$64.5K Buy
7,151
+2,234
+45% +$20.2K ﹤0.01% 5240
2023
Q4
$46.6K Buy
4,917
+1,502
+44% +$14.2K ﹤0.01% 5373
2023
Q3
$40.6K Sell
3,415
-316
-8% -$3.76K ﹤0.01% 5302
2023
Q2
$91.4K Sell
3,731
-5,999
-62% -$147K ﹤0.01% 5032
2023
Q1
$305K Sell
9,730
-12,884
-57% -$403K ﹤0.01% 4055
2022
Q4
$1.59M Buy
22,614
+20,151
+818% +$1.42M ﹤0.01% 2746
2022
Q3
$212K Buy
2,463
+2,213
+885% +$190K ﹤0.01% 4017
2022
Q2
$21K Sell
250
-16,041
-98% -$1.35M ﹤0.01% 5782
2022
Q1
$2.71M Buy
16,291
+6,479
+66% +$1.08M ﹤0.01% 2420
2021
Q4
$1.64M Buy
9,812
+7,873
+406% +$1.32M ﹤0.01% 3036
2021
Q3
$167K Sell
1,939
-4,721
-71% -$407K ﹤0.01% 4400
2021
Q2
$361K Buy
6,660
+6,159
+1,229% +$334K ﹤0.01% 3963
2021
Q1
$30K Sell
501
-97
-16% -$5.81K ﹤0.01% 6001
2020
Q4
$31K Buy
598
+229
+62% +$11.9K ﹤0.01% 5594
2020
Q3
$18K Sell
369
-415
-53% -$20.2K ﹤0.01% 5522
2020
Q2
$41K Sell
784
-1,021
-57% -$53.4K ﹤0.01% 5193
2020
Q1
$79K Sell
1,805
-120
-6% -$5.25K ﹤0.01% 4611
2019
Q4
$77K Buy
1,925
+172
+10% +$6.88K ﹤0.01% 5084
2019
Q3
$58K Buy
1,753
+1,430
+443% +$47.3K ﹤0.01% 5178
2019
Q2
$25K Buy
+323
New +$25K ﹤0.01% 5592
2019
Q1
Sell
-190
Closed -$45K 6986
2018
Q4
$45K Buy
190
+5
+3% +$1.18K ﹤0.01% 5285
2018
Q3
$40K Buy
+185
New +$40K ﹤0.01% 5431